Deborah Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions · Cardinal Health
Chief Executive Officer of Cardinal Health's Pharmaceutical and Specialty Solutions segment since September 2022. She was previously President of the Pharmaceutical Distribution division from 2017. Cardinal Health ranked No. 15 on the 2026 Fortune 500.
Last reviewed: Oct 1, 2026
Deborah Weitzman
Chief Executive Officer, Pharmaceutical and Specialty Solutions Cardinal Health
Last Reviewed: October 1, 2026
Executive Summary
Deborah Weitzman runs Cardinal Health’s pharmaceutical business, the Pharmaceutical and Specialty Solutions segment, as its chief executive, a role she has held since September 2022. She previously led the Pharmaceutical Distribution division as president from 2017. In fiscal 2026 Cardinal Health’s revenue rose 14 percent to $254.2 billion, mainly on growth in branded and specialty pharmaceutical sales. Cardinal Health ranked No. 15 on the 2026 Fortune 500.
Career Highlights
- Chief Executive Officer, Pharmaceutical and Specialty Solutions segment since September 2022.
- President, Pharmaceutical Distribution division, July 2017 to September 2022, also launching and overseeing the Outcomes pharmacy solutions business.
- Earlier Senior Vice President and General Manager of Cardinal Health Puerto Rico.
Professional Journey
Weitzman earned a bachelor’s degree in history at Dartmouth College and a master’s degree at Northwestern University’s Kellogg Graduate School of Management. She began her career in banking at J.P. Morgan, followed by consumer brand marketing roles in the United States and Puerto Rico, and then held roles of increasing responsibility at Johnson & Johnson Medical Caribbean.
At Cardinal Health she held leadership roles across sales and distribution operations, including Senior Vice President and General Manager of Cardinal Health Puerto Rico, responsible for operations in Puerto Rico and Latin America. She was President of the Pharmaceutical Distribution division from July 2017, and led the launch of Outcomes, which brings together patient engagement, clinical intervention and pharmacy workflow solutions.
In September 2022 she became chief executive of the company’s pharmaceutical segment, now called Pharmaceutical and Specialty Solutions.
Education
Dartmouth College
Bachelor’s degree, History
Northwestern University, Kellogg Graduate School of Management
Master’s degree
